Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice

Aging

Volumn 7, Issue 7, 2015, Pages 475-485

  Demyanenko, Ilya A ^a   Popova, Ekaterina N ^a   Zakharova, Vlada V ^a   Ilyinskaya, Olga P ^a   Vasilieva, Tamara V ^a   Romashchenko, Valeria P ^a   Fedorov, Artem V ^a   Manskikh, Vasily N ^a   Skulachev, Maxim V ^a   Zinovkin, Roman A ^a   Pletjushkina, Olga Yu ^a   Skulachev, Vladimir P ^a   Chernyak, Boris V ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Mitochondria targeted antioxidant; Mitochondrial reactive oxygen species; Wound healing

Indexed keywords

10-(6'-PLASTOQUINONYL)DECYLTRIPHENYLPHOSPHONIUM; ANTIOXIDANT; CADHERIN; CYTOKINE; PLASTOQUINONE; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AGING; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CBA MOUSE; CELL MOTION; DRUG EFFECTS; EPITHELIUM; GROWTH, DEVELOPMENT AND AGING; INJURIES; METABOLISM; MITOCHONDRION; MOUSE; MYOFIBROBLAST; SKIN; WOUND HEALING;

AGING; ANIMALS; ANTIOXIDANTS; CADHERINS; CELL MOVEMENT; CYTOKINES; EPITHELIUM; EXTRACELLULAR MATRIX PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MITOCHONDRIA; MYOFIBROBLASTS; PLASTOQUINONE; REACTIVE OXYGEN SPECIES; SKIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84931342218     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100772     Document Type: Article

References (61)

1. Gosain A and DiPietro LA. Aging and wound healing. World J Surg. 2004; 28: 321-326.
2. Schafer M and Werner S. Oxidative stress in normal and impaired wound repair. Pharmacol Res. 2008; 58: 165-171.
3. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004; 4: 181-189.
4. Abid MR, Spokes KC, Shih SC and Aird WC. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem. 2007; 282: 35373-35385.
5. Frey RS, Ushio-Fukai M and Malik AB. NADPH oxidasedependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal. 2009; 11: 791-810.
6. Van Buul JD, Fernandez-Borja M, Anthony EC and Hordijk PL. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal. 2005; 7: 308-317.
7. Xu S and Chisholm Andrew D. C. elegans Epidermal Wounding Induces a Mitochondrial ROS Burst that Promotes Wound Repair. Developmental Cell. 2014; 31: 48-60.
8. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS and Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011; 472: 476-480.
9. Corda S, Laplace C, Vicaut E and Duranteau J. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol. 2001; 24: 762-768.
10. Hughes G, Murphy MP and Ledgerwood EC. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factorinduced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem J. 2005; 389: 83-89.
11. Zinovkin RA, Romaschenko VP, Galkin, II, Zakharova VV, Pletjushkina OY, Chernyak BV and Popova EN. Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. Aging. 2014; 6: 661-674.
12. Wang Y, Zang QS, Liu Z, Wu Q, Maass D, Dulan G, Shaul PW, Melito L, Frantz DE, Kilgore JA, Williams NS, Terada LS and Nwariaku FE. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am J Physiol Cell Physiol. 2011; 301: C695-704.
13. Schleicher M, Shepherd BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, Acevedo LM, Shadel GS and Sessa WC. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol. 2008; 180: 101-112.
14. Velarde MC, Flynn JM, Day NU, Melov S and Campisi J. Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin. Aging (Albany NY). 2012; 4: 3-12.
15. Marrotte EJ, Chen DD, Hakim JS and Chen AF. Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J Clin Invest. 2010; 120: 4207-4219.
16. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP and Sammut IA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 2005; 19: 1088-1095.
17. Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassegue B, Griendling KK, Harrison DG and Dikalova AE. Nox2-induced production of mitochondrial superoxide in angiotensin IImediated endothelial oxidative stress and hypertension. Antioxid Redox Signal. 2014; 20: 281-294.
18. Gioscia-Ryan RA, LaRocca TJ, Sindler AL, Zigler MC, Murphy MP and Seals DR. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice. J Physiol. 2014; 592: 2549-2561.
19. Lowes DA, Thottakam BM, Webster NR, Murphy MP and Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharidepeptidoglycan model of sepsis. Free Radic Biol Med. 2008; 45: 1559-1565.
20. Zang QS, Sadek H, Maass DL, Martinez B, Ma L, Kilgore JA, Williams NS, Frantz DE, Wigginton JG, Nwariaku FE, Wolf SE and Minei JP. Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model. Am J Physiol Heart Circ Physiol. 2012; 302: H1847-1859.
21. Plotnikov EY, Chupyrkina AA, Jankauskas SS, Pevzner IB, Silachev DN, Skulachev VP and Zorov DB. Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion. Biochim Biophys Acta. 2011; 1812: 77-86.
22. Plotnikov EY, Silachev DN, Jankauskas SS, Rokitskaya TI, Chupyrkina AA, Pevzner IB, Zorova LD, Isaev NK, Antonenko YN, Skulachev VP and Zorov DB. Mild uncoupling of respiration and phosphorylation as a mechanism providing nephro- and neuroprotective effects of penetrating cations of the SkQ family. Biochemistry (Mosc). 2012; 77: 1029-1037.
23. Plotnikov EY, Morosanova MA, Pevzner IB, Zorova LD, Manskikh VN, Pulkova NV, Galkina SI, Skulachev VP and Zorov DB. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection. Proc Natl Acad Sci U S A. 2013; 110: E3100-3108.
24. Anisimov VN, Bakeeva LE, Egormin PA, Filenko OF, Isakova EF, Manskikh VN, Mikhelson VM, Panteleeva AA, Pasyukova EG, Pilipenko DI, Piskunova TS, Popovich IG, Roshchina NV, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry (Mosc). 2008; 73: 1329-1342.
25. Anisimov VN, Egorov MV, Krasilshchikova MS, Lyamzaev KG, Manskikh VN, Moshkin MP, Novikov EA, Popovich IG, Rogovin KA, Shabalina IG, Shekarova ON, Skulachev MV, Titova TV, et al. Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging (Albany NY). 2011; 3: 1110-1119.
26. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, et al. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta. 2009; 1787: 437-461.
27. Skulachev VP. Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases. J Alzheimers Dis. 2012; 28: 283-289.
28. Vays VB, Eldarov CM, Vangely IM, Kolosova NG, Bakeeva LE and Skulachev VP. Antioxidant SkQ1 delays sarcopeniaassociated damage of mitochondrial ultrastructure. Aging (Albany NY). 2014; 6: 140-148.
29. Skulachev MV, Antonenko YN, Anisimov VN, Chernyak BV, Cherepanov DA, Chistyakov VA, Egorov MV, Kolosova NG, Korshunova GA, Lyamzaev KG, Plotnikov EY, Roginsky VA, Savchenko AY, et al. Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Curr Drug Targets. 2011; 12: 800-826.
30. Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY). 2009; 1: 281-288.
31. Popova EN, Pletjushkina OY, Dugina VB, Domnina LV, Ivanova OY, Izyumov DS, Skulachev VP and Chernyak BV. Scavenging of reactive oxygen species in mitochondria induces myofibroblast differentiation. Antioxidants & redox signaling. 2010; 13: 1297-1307.
32. Demianenko IA, Vasilieva TV, Domnina LV, Dugina VB, Egorov MV, Ivanova OY, Ilinskaya OP, Pletjushkina OY, Popova EN, Sakharov IY, Fedorov AV and Chernyak BV. Novel mitochondriatargeted antioxidants, "Skulachev-ion" derivatives, accelerate dermal wound healing in animals. Biochemistry Biokhimiia. 2010; 75: 274-280.
33. Ashcroft GS, Horan MA and Ferguson MW. The effects of ageing on cutaneous wound healing in mammals. J Anat. 1995; 187: 1-26.
34. Ashcroft GS, Horan MA and Ferguson MW. Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J Invest Dermatol. 1997; 108: 430-437.
35. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007; 127: 526-537.
36. Sarrazy V, Billet F, Micallef L, Coulomb B and Desmouliere A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 2011; 19 Suppl 1:s10-15.
37. Moulin VJ, Mayrand D, Messier H, Martinez MC, Lopez-Valle CA and Genest H. Shedding of microparticles by myofibroblasts as mediator of cellular cross-talk during normal wound healing. J Cell Physiol. 2010; 225: 734-740.
38. Ashcroft GS, Horan MA and Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest. 1998; 78: 47-58.
39. Swift ME, Burns AL, Gray KL and DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol. 2001; 117: 1027-1035.
40. Herren B, Levkau B, Raines EW and Ross R. Cleavage of betacatenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell. 1998; 9: 1589-1601.
41. Sidibe A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, Le Loet X, Vittecoq O and Vilgrain I. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage. Arthritis Rheum. 2012; 64: 77-87.
42. Menke NB, Ward KR, Witten TM, Bonchev DG and Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007; 25: 19-25.
43. Galkin, II, Pletjushkina OY, Zinovkin RA, Zakharova VV, Birjukov IS, Chernyak BV and Popova EN. Mitochondria-targeted antioxidants prevent TNFalpha-induced endothelial cell damage. Biochemistry Biokhimiia. 2014; 79: 124-130.
44. Plotnikov EY, Chupyrkina AA, Pevzner IB, Isaev NK and Zorov DB. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochimica et biophysica acta. 2009; 1792: 796-803.
45. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C and Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3: 349-363.
46. Jain M, Rivera S, Monclus EA, Synenki L, Zirk A, Eisenbart J, Feghali-Bostwick C, Mutlu GM, Budinger GR and Chandel NS. Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling. J Biol Chem. 2013; 288: 770-777.
47. Jun JI and Lau LF. Cellular senescence controls fibrosis in wound healing. Aging (Albany NY). 2010; 2: 627-631.
48. Lee CH, Shah B, Moioli EK and Mao JJ. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest. 2010; 120: 3340-3349.
49. Shipounova I, Svinareva D, Petrova T, Lyamzaev K, Chernyak B, Drize N and Skulachev V. Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1. Mechanisms of ageing and development. 2010; 131: 415-421.
50. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH and et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986; 83: 4167-4171.
51. Brunner G and Blakytny R. Extracellular regulation of TGFbeta activity in wound repair: growth factor latency as a sensor mechanism for injury. Thromb Haemost. 2004; 92(2):253-261.
52. Verrecchia F and Mauviel A. Transforming growth factorbeta and fibrosis. World J Gastroenterol. 2007; 13: 3056-3062.
53. Yanai H, Taranukha D, Vierlinger K, Hofner M, Nöhammer C, Chilosi M, Budovsky A and Fraifeld VE. Wound healing and longevity: Lessons from long-lived αMUPA mice. Aging. 2015; 7: 167-176.
54. Blagosklonny MV. Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells. Rejuvenation Res. 2008; 11: 801-808.
55. Nuhrenberg TG, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J, Kountides M, Herter T, Baur R, Hombach V, Baeuerle PA and Zohlnhofer D. Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J. 2005; 19: 246-248.
56. Chen WQ, Zhong L, Zhang L, Ji XP, Zhang M, Zhao YX, Zhang C and Zhang Y. Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels. Br J Pharmacol. 2009; 156: 941-951.
57. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008; 7: 3344-3354.
58. Skulachev MV, Antonenko YN, Anisimov VN, Chernyak BV, Cherepanov DA, Chistyakov VA, Egorov MV, Kolosova NG, Korshunova GA, Lyamzaev KG, Plotnikov EY, Roginsky VA, Severina, II, et al. Mitochondrial-Targeted Plastoquinone Derivatives. Effect on Senescence and Acute Age-Related Pathologies. Curr Drug Targets. 2011; 12: 800-826.
59. Skulachev VP. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem Biophys Res Commun. 2013; 441: 275-279.
60. Chen C, Jamaluddin MS, Yan S, Sheikh-Hamad D and Yao Q. Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2008; 28: 906-912.
61. Ponce ML. Tube formation: an in vitro matrigel angiogenesis assay. Methods in molecular biology. 2009; 467: 183-188.